ClinConnect ClinConnect Logo
Search / Trial NCT06541977

A New Model of Exercise Referral Scheme Before and After Bariatric Surgery for People With Obesity

Launched by FUNDACIÓ UNIVERSITÀRIA DEL BAGES · Aug 2, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Bariatric Surgery Physical Activity Quality Of Life Obesity

ClinConnect Summary

The B-FIT (Bariatric surgery and FITness) project is a clinical trial designed to help people with obesity improve their health and maintain weight loss before and after bariatric surgery. This study aims to create a new program that supports physical activity and reduces sedentary behavior, which means less time spent sitting. The goal is to prevent weight regain after surgery and encourage healthier lifestyles. Bariatric surgery is a procedure that helps people lose weight, but many find it challenging to keep the weight off in the long run. By focusing on exercise and active living, this trial hopes to improve overall quality of life for participants.

To be eligible for this study, participants should be adults aged 18 to 65 with a Body Mass Index (BMI) of 35 or higher, along with related health issues like diabetes or hypertension, or a BMI of 40 or higher without any health problems. Candidates must be approved for bariatric surgery by their doctor and be willing to commit to the study's requirements, including follow-up assessments. However, people with a history of previous bariatric surgery, certain medical conditions that limit physical activity, or severe psychiatric issues cannot join. Participants can expect a supportive environment that encourages physical activity and promotes long-term healthy habits.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: Adults aged 18-65 years.
  • BMI: Body Mass Index (BMI) ≥ 35 kg/m² with associated comorbidities (e.g., type II diabetes, hypertension) or BMI ≥ 40 kg/m² without comorbidities.
  • Eligibility for Bariatric Surgery: Candidates must be approved for bariatric surgery by their healthcare provider.
  • Consent: Willingness to participate in the study, including signing an informed consent form.
  • Commitment: Ability to commit to the study protocol, including pre-surgery and post-surgery interventions and follow-up assessments.
  • Stable Medication: Participants must be on a stable medication regimen for any existing conditions for at least three months prior to the study.
  • Exclusion Criteria:
  • Previous Bariatric Surgery: Individuals who have undergone any form of bariatric surgery previously.
  • Medical Conditions: Presence of medical conditions that contraindicate physical activity, such as severe cardiovascular disease, uncontrolled hypertension, or orthopedic conditions that limit mobility.
  • Psychiatric Disorders: Severe psychiatric disorders or substance abuse issues that might impair the ability to comply with the study protocol.
  • Pregnancy: Pregnant or planning to become pregnant during the study period. Participation in Other Studies: Currently participating in another clinical trial or weight loss program.
  • Non-compliance Risk: Any other condition or factor that the investigators believe would prevent the participant from complying with the study protocol or that would put the participant at risk.

About Fundació Universitària Del Bages

Fundació Universitària del Bages is a leading academic foundation dedicated to advancing healthcare research and education. Based in Catalonia, Spain, it collaborates with various institutions to foster innovation in clinical practices and enhance patient care. The foundation is committed to conducting high-quality clinical trials that contribute to medical knowledge and improve therapeutic outcomes. With a focus on multidisciplinary approaches, Fundació Universitària del Bages aims to bridge the gap between academia and clinical practice, promoting a research-driven environment that supports the development of new treatments and healthcare solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Guillem Jabardo Camprubí, PhD

Principal Investigator

Faculty of Health Science at Manresa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported